Acadia Pharmaceuticals

Based in CA

🤖

AI Overview

With $7.3M in lobbying spend across 24 quarterly filings, Acadia Pharmaceuticals is one of the biggest lobbying spenders in Washington. Their lobbying covers 6 issue areas. Active from 2020 to 2025.

$7.3M
Total Spend
6
Years Active
1
Firms Hired
3
Lobbyists Deployed
6
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2020$190K
2021$840K
2022$1.5M
2023$1.0M
2024$1.4M
2025$2.3M

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Acadia Pharmaceuticals disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATETreasury, Dept ofFood & Drug Administration (FDA)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Budget/Appropriations, Defense, Trade and 1 more

Issues affecting the pharmaceutical industry

Drug pricing issues

Medicare reform; Telehealth issues

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.